# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4032010 | T | Mutagenicity in Salmonella typhimurium TA98/TA100 assessed as revertant colonies/plate in absence of rat liver S9 fraction at 10 ug/spot after 2 to 3 days by Ames test | Salmonella enterica subsp. enterica serovar Typhimurium | 3 | assay format | Scientific Literature | ||
2. | ALA4032011 | F | Antimicrobial activity against Chlamydia trachomatis serovar LGV-L2 454/Bu infected in human HeLa229 cells assessed as concentration required to reduce reinfection levels by >= 95% measured 44 to 48 hrs post infection by DAPI staining-based assay | Chlamydia trachomatis | 15 | cell-based format | Scientific Literature | ||
3. | ALA4032012 | A | Cytotoxicity against human HeLa229 cells assessed as cell viability at 10 uM after 44 to 48 hrs by resazurin-based fluorometry relative to control | Homo sapiens | 15 | cell-based format | Scientific Literature | ||
4. | ALA4032013 | F | Antimicrobial activity against Chlamydia trachomatis serovar LGV-L2 454/Bu infected in human HeLa229 cells assessed as reduction in reinfection levels measured 44 to 48 hrs post infection by DAPI staining-based assay | Chlamydia trachomatis | 5 | cell-based format | Scientific Literature | ||
5. | ALA4032014 | F | Antimicrobial activity against Chlamydia trachomatis serovar D UW-3 infected in human HeLa229 cells assessed as reduction in reinfection levels measured 44 to 48 hrs post infection by DAPI staining-based assay | Chlamydia trachomatis | 5 | cell-based format | Scientific Literature | ||
6. | ALA4032015 | T | Mutagenicity in Salmonella typhimurium TA98/TA100 assessed as revertant colonies/plate in presence of rat liver S9 fraction at 10 ug/spot after 2 to 3 days by Ames test | Salmonella enterica subsp. enterica serovar Typhimurium | 3 | assay format | Scientific Literature | ||
7. | ALA4032016 | T | Mutagenicity in Salmonella typhimurium TA1535/TA1538 assessed as revertant colonies/plate in presence of rat liver S9 fraction at 10 ug/spot after 2 to 3 days by Ames test | Salmonella enterica subsp. enterica serovar Typhimurium | 3 | assay format | Scientific Literature | ||
8. | ALA4032017 | T | Mutagenicity in Salmonella typhimurium TA1535/TA1538 assessed as revertant colonies/plate in absense of rat liver S9 fraction at 10 ug/spot after 2 to 3 days by Ames test | Salmonella enterica subsp. enterica serovar Typhimurium | 3 | assay format | Scientific Literature | ||
9. | ALA4032018 | A | Growth inhibition of Escherichia coli CCUG 17620 at 10 ug/ml after 24 hrs by disk diffusion method | Escherichia coli | 2 | assay format | Scientific Literature | ||
10. | ALA4032019 | A | Growth inhibition of Staphylococcus aureus CCUG 1800 at 10 ug/ml after 24 hrs by disk diffusion method | Staphylococcus aureus | 2 | assay format | Scientific Literature | ||
11. | ALA4032020 | A | Growth inhibition of Lactobacillus jensenii CCUG 33572 at 10 ug/ml after 24 hrs by disk diffusion method | Lactobacillus jensenii | 2 | assay format | Scientific Literature | ||
12. | ALA4032021 | A | Growth inhibition of Streptococcus agalactiae CCUG 4208 at 10 ug/ml after 24 hrs by disk diffusion method | Streptococcus agalactiae | 2 | assay format | Scientific Literature | ||
13. | ALA4032022 | A | Growth inhibition of Candida albicans at 10 ug/ml after 24 hrs by disk diffusion method | Candida albicans | 2 | assay format | Scientific Literature | ||
14. | ALA4032023 | F | Antimicrobial activity against Chlamydia trachomatis serovar LGV-L2 454/Bu expressing mCherry infected in human HeLa cells assessed as reduction in reinfection levels at 0.5 uM incubated for 48 hrs by BODIPY 22-based confocal microscopy | Chlamydia trachomatis | 2 | cell-based format | Scientific Literature | ||
15. | ALA4032024 | F | Antimicrobial activity against Chlamydia trachomatis serovar LGV-L2 454/Bu infected in human HeLa229 cells at 1 uM compound treated during 48 hrs of infection by DAPI staining-based assay | Chlamydia trachomatis | 2 | cell-based format | Scientific Literature | ||
16. | ALA4032025 | F | Antimicrobial activity against Chlamydia trachomatis serovar LGV-L2 454/Bu infected in human HeLa229 cells at 1 uM compound treated during first 24 hrs of infection by DAPI staining-based assay | Chlamydia trachomatis | 2 | cell-based format | Scientific Literature |